Houston Methodist Uses AI to Detect High-Risk Bloodstream Infection Patients

New study finds AI can identify distinct patient clusters and risk levels for deadly bloodstream infections.

Mar. 10, 2026 at 3:44am

Got story updates? Submit your updates here. ›

Researchers at Houston Methodist Research Institute have developed an AI-powered model that can analyze data from the first 48 hours of a bloodstream infection diagnosis to identify high-risk patient groups. The study, published in the American Journal of Transplantation, used unsupervised machine learning to cluster over 15,000 patients into three distinct groups based on factors like illness severity and need for organ support. The highest-risk group included older, predominantly male patients as well as transplant recipients, who can have mortality rates as high as 60% from these infections.

Why it matters

Bloodstream infections can be deadly, especially for patients with weakened immune systems like transplant recipients. This AI model provides a new way for clinicians to quickly assess a patient's risk level and take appropriate action to improve outcomes for high-risk individuals.

The details

The study, led by Dr. Masayuki Nigo, used an unsupervised machine learning approach to analyze clinical data from the first 48 hours after a bloodstream infection diagnosis. The model identified three distinct patient clusters - one high-risk group that required more intensive organ support, and two lower-risk groups with varying symptom severity. The high-risk group included older, predominantly male patients as well as transplant recipients, who are especially susceptible to infections and can have mortality rates up to 60%.

  • The study was published in the American Journal of Transplantation in March 2026.

The players

Houston Methodist Research Institute

A leading academic medical center and research institute in Houston, Texas.

Masayuki Nigo, M.D.

Associate professor in the Department of Medicine at Houston Methodist and lead author of the study.

Stefano Casarin, Ph.D.

Assistant professor in the Center for Precision Surgery at Houston Methodist Research Institute and co-author of the study.

Got photos? Submit your photos here. ›

What they’re saying

“This study is important because it demonstrates that patients with bloodstream infections, including solid organ transplant recipients, are not clinically uniform despite sharing the same diagnosis.”

— Masayuki Nigo, M.D., Associate Professor, Department of Medicine, Houston Methodist

“Our model turns routine early data into a risk map clinicians can use immediately. This gives us a new way to understand and predict how sick a patient might become. If we can identify high‑risk patients sooner, we can act sooner.”

— Stefano Casarin, Ph.D., Assistant Professor, Center for Precision Surgery, Houston Methodist Research Institute

What’s next

The researchers plan to validate the findings in external healthcare systems to confirm reproducibility and conduct further studies to improve the methodology for better clinical decision-making and patient outcomes.

The takeaway

This AI-powered model provides a new tool for clinicians to quickly identify high-risk bloodstream infection patients, especially vulnerable populations like transplant recipients, so they can intervene sooner and potentially improve survival rates for these deadly infections.